Brigatinib - Takeda
At a glance
- Drug Originator ARIAD Pharmaceuticals
- Drug Licenced by Biologics Inc
- Drug Class Antineoplastics; Diamines; Piperazines; Piperidines; Pyrimidines; Small molecules
- Mechanism of Action Anaplastic lymphoma kinase inhibitors; Cytochrome P-450 enzyme system stimulants; Epidermal growth factor receptor antagonists; ROS1 protein inhibitors
- USA Patent Applicants TAKEDA PHARMS USA
- USA Patents 6
- NDAs 1
- International Patents 90
- Patent Applications 1,541
Table of Contents
Disclaimer